That silence is the awkward part. A person can feel strong, train hard and sleep well while their arteries carry a lifelong cholesterol load. The signs that do exist are visual and numerical rather than things you notice day to day, which is why this condition is found in bloodwork and in family history far more often than in a symptom diary.
Most high cholesterol readings reflect everyday factors rather than an inherited condition. Lipid numbers move with recent eating patterns, body weight, alcohol intake, activity, sleep and stress, and they also drift with life stage. Before anyone considers an inherited cause, the ordinary explanations come first.
None of those is a diagnosis on its own. They are reasons a single number can look worse (or better) than your underlying biology, and they are the reason a clinician usually repeats a surprising lipid result before acting on it.
Familial hypercholesterolemia sits in a different category. It is an inherited disorder of LDL clearance in which LDL cholesterol is raised from birth and stays raised through adult life 1. Because the cause is genetic rather than behavioural, the number tends to stay well above typical ranges even when sleep, training and diet are in good order. Meta-analyses of general populations estimate heterozygous familial hypercholesterolemia in roughly 1 in 300 adults 2, and a separate systematic review put the estimate closer to 1 in 250 3. Studies suggest that a large share of affected people have never been identified 4.
As for what people actually notice, the physical signs described in clinical reviews are deposits of cholesterol in tissue. These include thickening of the Achilles or knuckle tendons, yellowish patches on or around the eyelids, and a pale ring at the outer edge of the cornea 5. These findings are helpful when present but are far from universal, and they tend to appear later in adult life rather than early 6. Plenty of adults with a lifelong high LDL have none of them.
Three blood markers carry most of the signal here, and a lipid panel on its own may not be enough. The table below shows what each one contributes and where it stops.
| Marker | Why it is linked to these signs | What a result can and cannot tell you |
|---|---|---|
| LDL cholesterol | The central measurement. An inherited fault in LDL clearance leaves LDL cholesterol high from birth and resistant to the usual lifestyle levers 1 | A very high value is the main trigger for further assessment. It cannot, by itself, confirm an inherited cause, because other conditions and life stages also raise it 4 |
| Lipoprotein (a) | An LDL-like particle whose cholesterol content is counted inside a standard LDL result, and which clinicians review when LDL is very high | Shows whether an extra atherogenic particle is adding to the picture. It cannot tell you how much plaque exists or when it formed |
| Apolipoprotein B | Each atherogenic particle carries one apolipoprotein B molecule, so the value reflects particle number rather than the cholesterol they carry | Useful when LDL cholesterol alone is hard to read. It cannot distinguish an inherited cause from a secondary one |
Typical lab reporting for adults looks like this. These are typical lab reference ranges, not targets set for any individual.
| Marker | Typical adult reporting | Units |
|---|---|---|
| LDL cholesterol | Optimal under 100, near optimal 100 to 129, borderline high 130 to 159, high 160 to 189, very high 190 and above | mg/dL |
| Apolipoprotein B | Many labs report a reference limit around 90 to 100 | mg/dL |
| Lipoprotein (a) | Commonly flagged at or above roughly 50 mg/dL, about 125 nmol/L, depending on the assay | mg/dL or nmol/L |
Reference ranges vary by laboratory, age and sex, and the units used for lipoprotein(a) differ between assays, so compare a result against the range printed on your own report.
Yes, and that pattern is one of the strongest clues. Liver cells pull LDL particles out of the bloodstream using LDL receptors. When an inherited variant reduces the number or function of those receptors, particles stay in circulation longer and the measured concentration sits high from the earliest years of life 1. Studies indicate that the clinical picture is driven mainly by variants affecting the LDL receptor, with smaller contributions from the apolipoprotein B and PCSK9 genes 7.
The practical consequence is a number that behaves unusually. Someone cleans up their diet, drops body fat, trains consistently, and the LDL falls a little but remains far above typical ranges. In clinical scoring systems, a very high untreated LDL combined with a family history of early coronary disease or with tendon deposits carries most of the weight 4. Research suggests that the lifelong exposure to raised LDL, rather than the level in any single year, is what drives the raised risk of early atherosclerotic disease in this group 1.
Other things move LDL too, which is why one reading is never the whole story. Thyroid function, protein loss through the kidneys, liver and bile flow problems, pregnancy, rapid weight change, alcohol and some medicines all shift the number, and acute illness can temporarily lower it. Clinical assessment considers these other causes of a raised LDL before an inherited cause is concluded 4. If you want the fuller picture of what a result reflects and how it is measured, the LDL Cholesterol marker page covers it.
Observation, meaning, next step. The observation is an LDL that stays high across repeat tests. The meaning may be an inherited clearance problem, or it may be one of the secondary causes above. The next step is a conversation with a clinician who can weigh your family history, your physical examination and the rest of your panel together.
Lipoprotein(a) adds a second, largely inherited source of atherogenic particles that a standard lipid panel does not separate out. It is an LDL-like particle carrying an extra protein, and the cholesterol it carries is included inside a routine LDL cholesterol measurement, which is one reason clinicians look at it when LDL is very high. Two people with identical LDL numbers can therefore have quite different particle profiles.
What else changes this marker? Less than you might hope. Concentration is set largely by genetics, so it does not swing much with a training block or a diet change. Kidney function, inflammation and hormonal changes such as pregnancy and the menopause transition can shift it somewhat, so a clinician reads one value in the context of what else is happening. Because it is stable, a single measurement is often enough for most adults, and your clinician decides whether a repeat adds anything. The Lipoprotein (a) page explains how the two unit systems differ and why that matters when comparing results between labs.
Because it counts particles instead of cholesterol. Every atherogenic lipoprotein in the blood carries exactly one apolipoprotein B molecule, so the measured value is a direct headcount of the particles that can lodge in an artery wall.
The mismatch cases are where it earns its place. A calculated LDL can read lower than the true particle burden when triglycerides are high, and it can read higher when lipoprotein(a) is elevated. Apolipoprotein B is measured directly and sidesteps both of those problems, which makes it a steadier reference point when numbers do not line up with the rest of the picture.
It is not a test for an inherited condition. A high apolipoprotein B says there are many atherogenic particles in circulation, not why. Insulin resistance, excess alcohol, recent weight gain and metabolic changes around the menopause transition all raise it, and so can an inherited lipid disorder. The value of the number is in refining risk and in giving a clinician a cleaner track to follow over time. The Apolipoprotein B page covers how it is measured and how it relates to the rest of the lipid panel.
Quite a lot, and it is worth being honest about the gaps. A lipid panel describes what is circulating in the blood today. It does not image your arteries, so it cannot say whether plaque has already formed or how much. Two adults with the same LDL can have very different arteries depending on how many years they have carried that number.
Family history is the second blind spot. Clinical criteria lean heavily on relatives with early coronary disease, usually counted as a heart attack before the mid fifties in men and the mid sixties in women 4. Many people simply do not know their family history in that detail, and an incomplete history can make a genuine inherited picture look like an isolated high reading.
Genetic testing fills part of the gap. An expert panel review describes how identifying a causative variant can confirm the diagnosis and support cascade testing of adult relatives who may carry the same variant without knowing it 8. The same review notes that a negative genetic test does not rule out the clinical diagnosis, because not every case has an identifiable variant 8. Studies indicate that the genetic architecture involves several genes and a spectrum of variants rather than a single switch 7, which is part of why the testing is not a simple yes or no.
Finally, blood markers say nothing about blood pressure, smoking history, sleep apnoea, visceral fat or fitness, all of which shape overall cardiovascular risk. A clean panel is reassuring. It is not a clearance certificate.
Seek urgent care for anything that looks like a heart or brain event, and arrange a prompt appointment for the slower warning signs. Chest pressure, tightness or pain, especially with exertion, breathlessness that is new or worsening, pain spreading to the arm, neck or jaw, or a cold sweat with any of these, all mean emergency care now rather than an appointment next week. Sudden face drooping, arm weakness or trouble speaking means calling emergency services immediately.
Book promptly, rather than urgently, for these.
None of these confirms a condition by itself. They are reasons to have your lipids reviewed properly rather than reasons to self-diagnose, and a clinician will want repeat testing plus an examination before drawing any conclusion.
If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.
All three are standard blood tests, usually drawn at the same time. The FitScript Essential panel measures LDL cholesterol, apolipoprotein B and lipoprotein(a) alongside the rest of a baseline workup, as part of 150+ biomarkers tested per year. Atlas, FitScript's AI health advisor, explains what each result means in plain language and shows how the numbers move between draws, so a single odd reading is not mistaken for a trend.
What happens next depends on the whole picture rather than one value. A clinician weighs repeat lipid results, your family history, a physical examination and your other risk factors, and decides whether genetic testing or further assessment is worthwhile 8. Treatment decisions belong to a licensed provider, who evaluates whether any option is appropriate after reviewing your history.
This article is educational and not medical advice. Discuss your results and any treatment with a clinician or licensed provider before changing anything.
For related reading, see what causes plaque in arteries, the practical levers behind how to reduce ldl cholesterol, and what a calcium heart scan can show that bloodwork cannot.
Usually not. Most adults with the condition feel completely well, which is why it is typically found through bloodwork or after a relative has an early cardiac event. The signs that do exist are a persistently very high LDL cholesterol and, in some people, visible cholesterol deposits in tendons or around the eyes.
They show up as firm thickening or lumps over tendons, most often the Achilles tendon at the back of the ankle or the extensor tendons on the backs of the knuckles. Around the eyes they can appear as soft yellowish patches on the eyelids or a pale ring at the edge of the cornea. They are not present in everyone, so their absence tells you very little.
No. One result is a prompt for further assessment, not a conclusion. A clinician will usually repeat the test, review your family history, examine you for physical signs, and consider thyroid, kidney, liver and life-stage factors that also raise LDL before reaching any view.
Yes, they matter for everyone, but in people with an inherited clearance problem the LDL tends to stay well above typical ranges even with excellent habits. That pattern is itself useful information for your clinician. Any decision about next steps belongs to a licensed provider who has reviewed your full picture.
LDL cholesterol measures how much cholesterol is being carried inside LDL particles. Apolipoprotein B counts the particles themselves, because each atherogenic particle carries exactly one of these proteins. The two usually move together, and the gap between them is most informative when triglycerides are high or lipoprotein(a) is elevated.
For most adults a single measurement is enough, because the level is set largely by genetics and changes little over a lifetime. Kidney function, inflammation and hormonal changes can shift it somewhat. Your clinician decides whether repeating it would add anything useful.
Testing first-degree adult relatives is a standard part of how this condition is identified, since siblings and parents share the same inherited pattern. A clinician arranges and interprets that testing. A simple lipid panel is usually the starting point for a relative who has never been checked.
Not always. A clinician decides whether genetic testing would change anything based on your lipid results, family history and examination. A variant found on testing can confirm the picture and help relatives get checked, while a negative result does not rule out the clinical diagnosis.